Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new ...

January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...

There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

Aragen unveils CHOMax, an accelerated platform for DNA to IND-enabling clinical supply in 10 months: Our Bureau, Bengaluru Monday, January 12, 2026, 14:15 Hrs [IST] Aragen launche ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir® platform.

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...